Research Themes
-
HIV Treatment Outcomes and Guidelines
-
Linkage, Retention and Adherence for HIV Treatment in South Africa
-
Costs, Cost-Effectiveness and Benefits of HIV Care and Treatment
-
Tuberculosis and HIV in South Africa
-
Cost and Budget Modelling
-
Sexual and Reproductive Health
-
Primary Health Care
-
Non-Communicable Diseases
-
Research Capacity Building
-
Policy Briefs
How effective is routine tracing of HIV treatment clients who interrupt care? Results from primary healthcare clinics in Gauteng Province, South Africa
- Among clients for whom either telephone or physical (home visit) tracing was attempted roughly half could be contacted.
- Of those who could be contacted, two thirds returned to care after tracing (about a third of all of those for whom tracing
was attempted); there was little difference in outcomes between telephone and physical
-
Journal Articles
Spousal salience in an aging rural South African cohort
Abstract
Background: The importance of the spousal relationship within one’s social circle—which we refer to as spousal salience—may have important implications for married individuals’ outcomes as they age.
Objective: This study investigates factors that may be associated with spousal salience among a sample of aging adults in rural South Africa.
Methods: We ... -
Journal Articles
Optimising scale-up of injectable lenacapavir for HIV pre-exposure prophylaxis in South Africa: A modelling study and economic evaluation
South Africa accounts for 20% of global HIV infections. Six-monthly injectable
lenacapavir (LEN) for HIV pre-exposure prophylaxis (PrEP) has superior efficacy
to oral tenofovir disoproxil fumarate/emtricitabine (TDF/FTC), and similar efficacy
to 2-monthly injectable cabotegravir (CAB). With LEN’s regulatory approval, South
Africa faces critical implementation decisions amid constrained domestic resources
and ...
-
HE²RO at IAS 2026!
HE²RO is excited to be part of the AIDS 2026 Conference, with a strong line-up of presentations that includes a pre-conference presentation (by invitation), a satellite session from the Evaluating the Cost of Scaling PrEP Access through Novel Delivery (EXPAND) project, an oral presentation at the Lancet satellite session, and 10 poster presentations showcasing research ...
-
Brief 17: The Economics of HIV and of HIV Programmes in the Era of Covid-19
Key Points
...A FRAMEWORK FOR CONSIDERING THE IMPACT OF COVID-19 ON THE ECONOMICS OF HIV The Covid-19 pandemic has profound negative implications for the economies of countries most affected by HIV, as well as for donor countries -
Brief 16: Trade-offs within the HIV Budget
Key Points
- Governments need to choose between different HIV interventions in order to maximise impact under limited funding. This can be done by ordering interventions by cost-effectiveness in a league table, or by employing allocative efficiency models to determine how to allocate funds across packages of interventions in the most cost-effective way.
- here
-
Brief 15: Public and Private Provision of Health and HIV Services
Key Points
- Private sector provision of health services – through for-profit, not-for-profit and informal providers – is widespread in low- and middle-income countries, and has played a role in the provision of HIV services.
- Public-private partnerships describe more evolved collaborations between the government, the private sector and, frequently, donors, and have played a role
Research Programs
-
Indlela: Behavioural Insights for Better Health 2.0
-
Economic Impact of HIV
-
Undetectable=Untransmittable” into HIV Counselling in South Africa (INTUIT 2.0-SA)
-
Retain6: Models of care for the first 6 months of HIV treatment
-
South African HIV Investment Case
-
Evaluating the Cost of Scaling PrEP Access through Novel Delivery (EXPAND)
-
SHIFT
-
AMBIT 2.0
Stay up to date
Receive newsletters and keep up to date with developments at HE2RO.
News
-
HE²RO at IAS 2026!
HE²RO is excited to be part of the AIDS 2026 Conference, with a strong line-up of presentations that includes a pre-conference presentation (by invitation),...
-
Brief 17: The Economics of HIV and of HIV Programmes in the Era of Covid-19
Key Points A FRAMEWORK FOR CONSIDERING...
-
Brief 16: Trade-offs within the HIV Budget
Key Points Governments need to choose between different HIV interventions in order to maximise impact under limited funding. This can be done...
-
Analysis of National Lab Database to evaluate the HIV treatment rollout in South Africa
By linking lab tests on detailed patient identifiers, a national, patient-level longitudinal cohort is being developed, which contains over 3 million ART initiators and...
-
Tuberculosis and HIV in South Africa
South Africa has one of the most severe epidemics of tuberculosis in the world. TB incidence is at nearly 1%, and some 400,000 cases...
-
Costs, Cost-Effectiveness and Benefits of HIV Care and Treatment
For many developing countries the decision to offer HIV care and treatment, at what level and through which delivery model was influenced by...
-
HIV Treatment Outcomes and Guidelines
South Africa’s national antiretroviral therapy (ART) treatment program, the largest in the world with roughly 2.4 million people on treatment, has made substantial impact...
